Institution/Partner
CARE Hospitals (Psychiatry Dept.), Rainbow Children’s Hospital (Psychology Dept.), and CognitiveBotics Technologies Pvt. Ltd.
Methodology
A 12-month observational study involving 43 children (aged 2–18 years) diagnosed with ASD.
Participants were divided into:
- Intervention group (n=35): Received standard therapy + CognitiveBotics platform.
- Control group (n=5): Received only standard therapy.
Standardized assessments used:
- Childhood Autism Rating Scale (CARS)
- Vineland Social Maturity Scale (VSMS)
- Developmental Screening Test (DST)
- Receptive Expressive Emergent Language Test (REEL)
Key Findings
The intervention group showed statistically significant improvements (p < .001) across all domains:
- CARS score reduced by 15.18%
- Social Age increased by 56.84%
- Developmental Age increased by 46.49%
- Receptive Language improved by 56.22%
- Expressive Language improved by 59.93%
The control group showed marginal or non-significant changes in these domains.
- Status: Published in JMIR Neurotechnology, 2025; DOI: 10.2196/70589